Submissions for variant NM_174878.3(CLRN1):c.144T>G (p.Asn48Lys)

gnomAD frequency: 0.00016  dbSNP: rs111033258

Total submissions: 22

Submitter	RCV	SCV	Clinical significance	Condition	Last evaluated	Review status	Method	Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine	RCV000844692	SCV000065127	pathogenic	Rare genetic deafness	2017-07-05	criteria provided, single submitter	clinical testing	The p.Asn48Lys variant in CLRN1 is known to be pathogenic (Adato 2002, Fields 20 02, Ness 2003). It has been identified in 0.5% (53/9850) of Ashkenazi Jewish chr omosomes including 1 homozygote by the Genome Aggregation Database (gnomAD, http ://gnomad.broadinstitute.org; dbSNP rs111033258). This variant is common in the Ashkenazi Jewish population and it is thought to be a founder mutation. In summ ary, this variant meets criteria to be classified as pathogenic for Usher syndro me type III in an autosomal recessive manner.
Illumina Laboratory Services, Illumina	RCV000004645	SCV000441715	pathogenic	Usher syndrome type 3	2018-03-27	criteria provided, single submitter	clinical testing	The CLRN1 c.144T>G (p.Asn48Lys) variant is well described in the literature as a common pathogenic variant for Usher syndrome in the Ashkenazi Jewish population. Across four studies, the p.Asn48Lys variant was detected in a total of 38 individuals with Usher syndrome, including in 33 homozygotes, in two compound heterozygotes, and in three heterozygotes (Adato et al. 2002; Fields et al. 2002; Ness et al. 2003; Herrera et al. 2008). Haplotype analysis suggests a founder effect for this variant. The variant was detected in 4/1,059 control chromosomes and is reported at a frequency of 0.005381 in the Ashkenazi Jewish population of the Genome Aggregation Database. The p.Asp48Asn variant is conserved and disrupts the only N-glycosylation site in the protein. In vitro functional studies demonstrated that the variant results in misfolding, mislocalization and degradation of the protein, and an absence of the actin reorganizing function (Tian et al. 2009). Gopal et al. (2015) used transgenic zebrafish to show that the variant causes aberrant hair cell bundle morphology with diminished function. The variant protein mislocalizes to the cell body with only a small amount reaching the hair bundle. Based on the evidence, the p.Asp48Asn variant is classified as pathogenic for Usher syndrome. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.
GeneDx	RCV000489880	SCV000576656	pathogenic	not provided	2021-10-28	criteria provided, single submitter	clinical testing	Reported as the most common pathogenic variant in the CLRN1 gene among North Americans and is reported as a founder mutation in the Ashkenazi Jewish population (Adato et al., 2002; Herrera et al., 2008; Geng et al., 2012); Published functional studies demonstrate impaired Clrn1 protein localization to the cochlear hair cell bundle (Geng et al., 2012); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 12145752, 28041643, 25262649, 12080385, 22787034, 18281613, 14569126, 19423712, 26180195, 29490346, 31097578, 25333069, 28559085, 30924848, 31370859, 31456290, 31980526)
Women's Health and Genetics/Laboratory Corporation of America, LabCorp	RCV000004645	SCV000699978	pathogenic	Usher syndrome type 3	2016-11-03	criteria provided, single submitter	clinical testing	Variant summary: The CLRN1 c.144T>G (p.Asn48Lys) variant involves the alteration of a non-conserved nucleotide. 4/4 in silico tools predict a damaging outcome for this variant (SNPs&GO not captured due to low reliability index). This variant was found in 25/121408 control chromosomes at a frequency of 0.0002059, which does not exceed the estimated maximal expected allele frequency of a pathogenic CLRN1 variant (0.0033541). This variant has been frequently reported in Jewish USH3 patients and was suggested to be a founder mutation in Ashkenazi Jews. In vitro and in vivo studies showed that this variant leads to mislocalization of CLRN1, disruption of the hair bundle integrity, and hearing loss phenotype (Geng_2012). In addition, one clinical diagnostic laboratory classified this variant as pathogenic. Taken together, this variant is classified as pathogenic.
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories	RCV000999864	SCV000885202	pathogenic	not specified	2018-11-07	criteria provided, single submitter	clinical testing	The p.Asn48Lys variant (rs111033258; ClinVar variation ID: 4395) is a well-studied variant known to be causative of Usher syndrome, type 3A (USH3A, MIM: 276902); a disorder characterized by progressive hearing loss, retinitis pigmentosa, and variable peripheral vestibular dysfunction. This variant is thought to be an Ashkenazi Jewish (AJ) founder variant as is present in the AJ population at an estimated allele frequency of 0.35% (Ness 2003) through 0.53% (Genome Aggregation Database (gnomAD) browser). While often observed in homozygosity in AJ Usher patients, it has also been observed in heterozygosity with other pathogenic CLRN1 variants (Adato 2002, Fields 2002, Ness 2003, Herrera 2008. Isosomppi 2009). The asparagine at codon 48 had been experimentally demonstrated to be the sole site of glycosylation on the CLRN1 protein, which may explain the changes in protein localization and stability associated with p.Asn48Lys variant protein (Isosomppi 2000, Tian 2009, Geng 2012). Stable expression of p.Asn48Lys in a Zebrafish model also recapitulates the mis-location of variant protein (Gopal 2015). Finally, a mouse knock-in model of USH3A has demonstrated that mice homozygous for p.Asn48Lys have disrupted hair bundle organization and experience hearing loss by postnatal day 24 to a degree indistinguishable from homozygous CLRN1 knock out mice (Geng 2012). Taken together, we interpret the p.Asn48Lys variant as pathogenic.
Invitae	RCV000489880	SCV000947009	pathogenic	not provided	2024-01-31	criteria provided, single submitter	clinical testing	This sequence change replaces asparagine, which is neutral and polar, with lysine, which is basic and polar, at codon 48 of the CLRN1 protein (p.Asn48Lys). This variant is present in population databases (rs111033258, gnomAD 0.5%). This missense change has been observed in individuals with CLRN1-related conditions (PMID: 12080385, 14569126, 18281613). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 4395). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects CLRN1 function (PMID: 22787034, 26180195). For these reasons, this variant has been classified as Pathogenic.
Centre for Genomic Medicine, Manchester, Central Manchester University Hospitals	RCV000004645	SCV001156379	pathogenic	Usher syndrome type 3	2019-02-01	criteria provided, single submitter	clinical testing
Baylor Genetics	RCV000004645	SCV001162964	pathogenic	Usher syndrome type 3		criteria provided, single submitter	clinical testing
Myriad Genetics, Inc.	RCV000004645	SCV001193846	pathogenic	Usher syndrome type 3	2019-12-09	criteria provided, single submitter	clinical testing	NM_174878.2(CLRN1):c.144T>G(N48K) is classified as pathogenic in the context of Usher syndrome type 3. Sources cited for classification include the following: PMID 12080385, 12145752, 18281613, 19753315, 14569126 and12145752. Classification of NM_174878.2(CLRN1):c.144T>G(N48K) is based on the following criteria: This is a well-established pathogenic variant in the literature that has been observed more frequently in patients with clinical diagnoses than in healthy populations. Please note: this variant was assessed in the context of healthy population screening.
Blueprint Genetics	RCV001073333	SCV001238872	pathogenic	Retinal dystrophy	2018-11-22	criteria provided, single submitter	clinical testing
Ocular Genomics Institute, Massachusetts Eye and Ear	RCV001273483	SCV001573532	pathogenic	Usher syndrome type 3A	2021-04-08	criteria provided, single submitter	research	The CLRN1 c.144T>G variant was identified in an individual with retinitis pigmentosa with a presumed recessive inheritance pattern. Through a review of available evidence we were able to apply the following criteria: PS3, PP1-S, PM2, PM3. Based on this evidence we have classified this variant as Pathogenic.
Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard	RCV000504948	SCV001950235	pathogenic	Retinitis pigmentosa	2021-04-01	criteria provided, single submitter	curation	The p.Asn48Lys variant in CLRN1 was identified in an individual with Retinitis pigmentosa, via a collaborative study between the Broad Institute's Center for Mendelian Genomics and the Pierce lab (https://oculargenomics.meei.harvard.edu/labs/pierce-lab/lab-members/). Through a review of available evidence we were able to apply the following criteria: PS3, PP1-S, PM2, PM3. Based on this evidence we have classified this variant as Pathogenic. If you have any questions about the classification please reach out to the Pierce Lab.
Revvity Omics, Revvity	RCV000489880	SCV002023258	likely pathogenic	not provided	2023-10-24	criteria provided, single submitter	clinical testing
Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard	RCV001273483	SCV002507095	pathogenic	Usher syndrome type 3A	2022-05-04	criteria provided, single submitter	curation	The homozygous p.Asn48Lys variant in CLRN1 was identified by our study in 1 individual with Usher syndrome type 3A. The variant has been reported in at least 20 Ashkenazi Jewish individuals with Usher syndrome type 3A (PMID: 12080385, 145691260), segregated with disease in 12 affected relatives from 7 families (PMID: 145691260), and has been identified in 0.6% (58/10080) of Ashkenazi Jewish chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs111033258). Although this variant has been seen in the general population, its frequency is not high enough to rule out a pathogenic role. This variant has also been reported in ClinVar (Variation ID: 4395) as pathogenic by many submitters, as likely pathogenic by NIHR Bioresource Rare Diseases, University of Cambridge, and as having uncertain significance by Illumina Clinical Services Laboratory. Animal models in mice and zebrafish have shown that this variant causes Usher syndrome type 3A (PMID: 26180195, 22787034). Computational prediction tools and conservation analyses do not provide strong support for or against an impact to the protein. The presence of this variant in at least 20 affected homozygotes and in at least 20 individuals with Usher syndrome type 3A increases the likelihood that the p.Asn48Lys variant is pathogenic (PMID: 12080385, 145691260). In summary, this variant meets criteria to be classified as pathogenic for Usher syndrome type 3A in an autosomal recessive manner based on its homozygous occurrence and expected segregation pattern in affected individuals and families, as well as functional evidence that shows a damaging effect. ACMG/AMP Criteria applied: PS3, PP1_strong, PM3 (Richards 2015).
Fulgent Genetics, Fulgent Genetics	RCV002504744	SCV002811515	pathogenic	Retinitis pigmentosa; Retinitis pigmentosa 61; Usher syndrome type 3A	2022-02-12	criteria provided, single submitter	clinical testing
Baylor Genetics	RCV003466812	SCV004214400	pathogenic	Retinitis pigmentosa 61	2023-10-22	criteria provided, single submitter	clinical testing
OMIM	RCV000004645	SCV000024819	pathogenic	Usher syndrome type 3	2003-10-01	no assertion criteria provided	literature only
NIHR Bioresource Rare Diseases, University of Cambridge	RCV000504948	SCV000598873	likely pathogenic	Retinitis pigmentosa	2015-01-01	no assertion criteria provided	research
Sharon lab, Hadassah-Hebrew University Medical Center	RCV000004645	SCV001160991	pathogenic	Usher syndrome type 3	2019-06-23	no assertion criteria provided	research
Natera, Inc.	RCV001273483	SCV001456565	pathogenic	Usher syndrome type 3A	2020-09-16	no assertion criteria provided	clinical testing
Department of Pathology and Laboratory Medicine, Sinai Health System	RCV000489880	SCV001554304	pathogenic	not provided		no assertion criteria provided	clinical testing	The CLRN1 p.Asn48Lys variant was identified in 60 of 162 proband chromosomes (frequency: 0.37) from individuals or families with Usher Syndrome type IIIa and retinitis pigmentosa (RP) and was only identified in 3 of 838 chromosomes (frequency: 0.004) from healthy controls (Herrera_2008_PMID:18281613; Sadeghi_2005_PMID:16028794; Ness_2003_PMID:14569126). The variant was also identified in dbSNP (ID: rs111033258), LOVD 3.0 and in ClinVar (classified as pathogenic for Usher syndrome type 3A by Laboratory for Molecular Medicine, Illumina, GeneDx, Counsyl, ARUP Laboratories, Integrated Genetics and OMIM, likely pathogenic by NIHR Bioresource Rare Diseases and a VUS for dominant RP by Illumina Clinical Services Laboratory). The variant was found in control databases in 68 of 251460 chromosomes (1 homozygous) at a frequency of 0.00027 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: Ashkenazi Jewish in 58 of 10080 chromosomes (freq: 0.005754), Other in 1 of 6134 chromosomes (freq: 0.000163) and European (non-Finnish) in 9 of 113742 chromosomes (freq: 0.000079); it was not observed in the African, Latino, East Asian, European (Finnish) and South Asian populations. The N48K variant was identified in the homozygous state in a patient with RP and hearing loss and in the compound heterozygous state in a patient with hearing loss starting at age 7 (Tian_2009_PMID:19423712). Functional studies demonstrated that N48K mutants lacked N-linked glycosylation which led to misfolding, mislocalization, and degradation of the CLRN1 protein (Tian_2009_PMID:19423712). Animal models of the N48K variant in zebrafish and mice have also shown impaired CLRN1 localization and abnormal cochlear hair bundle morphology and function (Gopal_2005_ PMID:26180195; Geng_2012_PMID:22782034; Isosomppi_2009_PMID:19753315). The variant occurs outside of the splicing consensus sequence however 3 of 4 in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE) predict the loss of a 3' splice site; however this is not a known splice site. The p.Asn48 residue is conserved across mammals and other organisms, and four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, MutationTaster) suggest that the variant may impact the protein. In summary, based on the above information this variant meets our laboratory’s criteria to be classified as pathogenic.
GenomeConnect, ClinGen	RCV001824560	SCV002075200	not provided	Retinitis pigmentosa; Usher syndrome type 3A		no assertion provided	phenotyping only	Variant interpreted as Pathogenic and reported on 05-12-2021 by Lab or GTR ID 500188. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant.